The positioning a seller needs before taking this to an account.
• Regulatory Toxicology (1. ADE/PDE/Determination/ Report Services 2. F-Value Reports for Child Resistant Packaging (CRP) 3. Toxicological Risk Assessment (TRA) of impurities, Extractables & Leachables 4. Environmental Risk Assessment (ERA) of medicinal products) • Scientific and Regulatory Review of Non-clinical Documents • Development and Review of Study Plans/Protocols for Non-clinical Studies • Non-clinical Development Strategy for Regulatory Submissions • Consultation on Non-clinical Issues in the Submissions • Consultation and Responses to Regulatory Queries • GLP Audits of Test Facilities • CRO Identification and Qualification for Non-clinical Regulatory Studies
Available in various markets via in-house delivery team / FreyrX / both · SEND compilation & submission: No in-house capability currently
Account adoption, booked value, and renewal context in one place.
No commercial data yet. Add this offering to a customer to begin tracking adoption and revenue.
Seller-ready assets, ordered by the way they are typically used.
No sales materials have been added.
Other Freyr Service configurations worth considering for the same account.